Sabry Gabriel, MD
Family Medicine · Macon, GANPI 1730288424
Payments from drug & device makers
Across 281 payments — averaging $21.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Pfizer$633
- Novo Nordisk$606
- Amgen$533
- Lilly USA, LLC$484
- AstraZeneca$368
- plus $2K from 29 others
What the payments were for
- Food & beverage$5,898100%
- Education$230%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 45 | $1,108 |
| Pfizer | 38 | $633 |
| Novo Nordisk | 33 | $606 |
| Amgen(2 entities) | 35 | $533 |
| Lilly USA, LLC | 34 | $484 |
| AstraZeneca | 15 | $368 |
| Bayer | 11 | $305 |
| Sanofi-aventis U.S. LLC | 4 | $294 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $172 |
| Biosense Webster, Inc. | 1 | $148 |
| Astellas Pharma US Inc | 2 | $134 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $126 |
| Otsuka America Pharmaceutical, Inc. | 4 | $94 |
| GSK | 5 | $94 |
| Boehringer Ingelheim | 5 | $91 |
| Abbott | 4 | $76 |
| Corcept Therapeutics | 3 | $72 |
| Merck | 4 | $68 |
| Currax Pharmaceuticals LLC | 4 | $60 |
| Ardelyx, Inc. | 3 | $50 |
| Dexcom, Inc. | 2 | $46 |
| Lundbeck LLC | 2 | $45 |
| Idorsia Pharmaceuticals US Inc | 3 | $42 |
| Novartis | 2 | $40 |
| Medtronic | 1 | $36 |
| Kerecis Limited | 1 | $27 |
| Vertex | 1 | $25 |
| Amarin Pharma, Inc. | 1 | $25 |
| Alkermes, Inc. | 1 | $23 |
| Seqirus USA Inc | 1 | $22 |
| Medline Industries LP | 1 | $18 |
| IBSA Pharma Inc. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Exact Sciences | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,920 in reported general payments places this provider in the 85th percentile of 3,111 family medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 102 | $107,286 |
| EliquisApixaban | 135 | $99,729 |
| OzempicSemaglutide | 53 | $56,780 |
| JardianceEmpagliflozin | 69 | $50,429 |
| JanuviaSitagliptin Phosphate | 33 | $33,037 |
| Nurtec OdtRimegepant Sulfate | 12 | $20,002 |
| LinzessLinaclotide | 18 | $18,909 |
| FarxigaDapagliflozin Propanediol | 22 | $18,306 |
| MyrbetriqMirabegron | 22 | $14,247 |
| TrulicityDulaglutide | 13 | $12,627 |
| Atrovent HfaIpratropium Bromide | 14 | $8,163 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 396 | $8,008 |
| SymbicortBudesonide/Formoterol Fumarate | 15 | $6,086 |
| Breo ElliptaFluticasone/Vilanterol | 14 | $5,612 |
| Doxepin Hcl | 23 | $5,275 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Nurtec Odt, Premarin | $633 | $123,667158 claims |
| Lilly USA, LLCMounjaro, Trulicity | $484 | $119,912115 claims |
| Novo NordiskOzempic | $606 | $56,78053 claims |
| Boehringer IngelheimJardiance | $91 | $50,42969 claims |
| MerckJanuvia | $68 | $33,03733 claims |
| AstraZenecaFarxiga, Symbicort | $368 | $24,39337 claims |
| AbbVieLinzess, Synthroid | $1,108 | $20,50032 claims |
| Astellas Pharma US IncMyrbetriq | $134 | $14,24722 claims |
| GSKBreo Ellipta | $94 | $5,61214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Macon
- Frederick BurtonMacon$66K
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.